AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Atorvastatin; Perindopril Arginine; Amlodipine in Nigeria
5 products registered with NAFDAC — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Triveram 10-5-5 Tablets Tablet | C4-1735 | CHI Pharmaceutical Limited | active | 23 Jun 2026 |
| Triveram 20-10-5 Tablets Tablet | C4-1737 | CHI Pharmaceutical Limited | active | 23 Jun 2026 |
| Triveram 20-5-5 Tablets Tablet | C4-1736 | CHI Pharmaceutical Limited | active | 23 Jun 2026 |
| Triveram 20-10-10 Tablets Tablet | C4-1738 | CHI Pharmaceutical Limited | active | 23 Jun 2026 |
| Triveram 40-10-10 Tablets Tablet | C4-1739 | CHI Pharmaceutical Limited | active | 23 Jun 2026 |
Atorvastatin; Perindopril Arginine; Amlodipine — NAFDAC Registration Details
NAFDAC (Nigeria) has 5 registered products containing Atorvastatin; Perindopril Arginine; Amlodipine, of which 5 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Atorvastatin; Perindopril Arginine; Amlodipine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.